Goldman Sachs Portfolio holdings
Goldman Sachs, founded in 1869 by Marcus Goldman and later joined by Samuel Sachs, is a premier global investment bank headquartered in New York City, renowned for its influential role in financial markets. The firm provides a wide range of services, including investment banking (mergers, acquisitions, and underwriting), securities trading, asset management, and consumer banking through its Marcus platform, catering to corporations, governments, institutions, and high-net-worth individuals. Known for its elite status on Wall Street, Goldman Sachs has a history of navigating major economic events, from the Great Depression to the 2008 financial crisis, where it played a controversial yet pivotal role. With a strong emphasis on innovation and a global footprint, it manages billions in assets and remains a powerhouse in shaping economic policy and market trends.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.58B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$2.05B |
| 3 |
Alibaba
BABA
|
+$905M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$371M |
| 5 |
Kroger
KR
|
+$307M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.38B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.33B |
| 3 |
Microsoft
MSFT
|
+$961M |
| 4 |
Invesco QQQ Trust
QQQ
|
+$803M |
| 5 |
Amazon
AMZN
|
+$740M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.8% |
| 2 | Healthcare | 9.1% |
| 3 | Financials | 9.05% |
| 4 | Consumer Discretionary | 8.76% |
| 5 | Communication Services | 6.13% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2226
Acco Brands
ACCO
$400M
| $10.3M | ﹤0.01% |
1,455,008
+142,587
| +11% | +$887K |
|
2227
PUT
NextEra Energy
NEE
$179B
| $10.3M | ﹤0.01% |
172,000
-458,000
| -73% | -$27.4M |
|
2228
CALL
Chubb
CB
$135B
| $10.3M | ﹤0.01% |
+81,500
| New | +$9.44M |
|
2229
NETGEAR
NTGR
$651M
| $10.3M | ﹤0.01% |
398,090
+44,440
| +13% | +$1.08M |
|
2230
Kura Oncology
KURA
$828M
| $10.3M | ﹤0.01% |
631,712
+535,271
| +555% | +$7.72M |
|
|
ONC
2231
BeOne Medicines Ltd
ONC
$34.2B
| $10.3M | ﹤0.01% |
54,588
-34,332
| -39% | -$5.59M |
|
|
BCPC
2232
Balchem Corp
BCPC
$5.54B
| $10.3M | ﹤0.01% |
108,411
-2,597
| -2% | -$243K |
|
2233
ePlus
PLUS
$2.44B
| $10.3M | ﹤0.01% |
290,796
+191,164
| +192% | +$6.53M |
|
2234
Albertsons Companies
ACI
$5.71B
| $10.3M | ﹤0.01% |
+651,531
| New | +$10.2M |
|
2235
Enova International
ENVA
$6.54B
| $10.3M | ﹤0.01% |
690,959
-85,902
| -11% | -$1.19M |
|
2236
Puma Biotechnology
PBYI
$405M
| $10.3M | ﹤0.01% |
984,680
+291,227
| +42% | +$3.01M |
|
|
GDEN
2237
DELISTED
Golden Entertainment
GDEN
| $10.3M | ﹤0.01% |
1,149,538
-31,992
| -3% | -$298K |
|
2238
CALL
AstraZeneca
AZN
$251B
| $10.2M | ﹤0.01% |
96,800
+72,350
| +296% | +$7.47M |
|
2239
CALL
TSMC
TSM
$2.16T
| $10.2M | ﹤0.01% |
180,000
-795,000
| -82% | -$41.9M |
|
|
2240
PUT
TSMC
TSM
$2.16T
| $10.2M | ﹤0.01% |
+180,000
| New | +$9.49M |
|
2241
CALL
Amcor
AMCR
$22B
| $10.2M | ﹤0.01% |
+200,000
| New | +$9.33M |
|
2242
COPT Defense Properties
CDP
$4.23B
| $10.2M | ﹤0.01% |
402,801
-97,387
| -19% | -$2.43M |
|
2243
MACOM Technology Solutions
MTSI
$20.5B
| $10.2M | ﹤0.01% |
296,997
-1,545,824
| -84% | -$45.2M |
|
2244
iShares International Equity Factor ETF
INTF
$3.69B
| $10.2M | ﹤0.01% |
+445,000
| New | +$9.79M |
|
|
RPAI
2245
DELISTED
RETAIL PROPERTIES OF AMERICA, INC.
RPAI
| $10.2M | ﹤0.01% |
1,390,909
-1,040,811
| -43% | -$6M |
|
2246
Invesco KBW Bank ETF
KBWB
$6.96B
| $10.2M | ﹤0.01% |
266,125
+78,880
| +42% | +$2.95M |
|
2247
Independence Realty Trust
IRT
$4.02B
| $10.1M | ﹤0.01% |
881,405
+84,401
| +11% | +$842K |
|
|
MRSN
2248
DELISTED
Mersana Therapeutics
MRSN
| $10.1M | ﹤0.01% |
17,294
+13,866
| +404% | +$4.73M |
|
|
NUVA
2249
PUT
DELISTED
NuVasive, Inc.
NUVA
| $10.1M | ﹤0.01% |
181,700
+106,600
| +142% | +$6.17M |
|
|
EPZM
2250
DELISTED
Epizyme, Inc
EPZM
| $10.1M | ﹤0.01% |
629,668
+188,840
| +43% | +$3.3M |
|
Similar funds
Goldman Sachs's Q2 2020 Portfolio in Review
As of Q2 2020, Goldman Sachs held 5,697 positions worth $329B, up 16% from $284B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Goldman Sachs withdrew a net $19.5B in Q2 2020, closing 535 positions and reducing 2,401 holdings. Its most notable exit was Allergan plc, an estimated $1.33B position sold in full.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Goldman Sachs opened a new position in Goldman Sachs MarketBeta US Equity ETF worth $209M.
- Goldman Sachs's largest Q2 2020 buy was Goldman Sachs MarketBeta US Equity ETF: 4,910,076 shares worth $209M.
- Goldman Sachs added most to State Street SPDR S&P 500 ETF Trust in Q2 2020, an estimated $2.58B increase.
- Goldman Sachs's biggest Q2 2020 reduction was Apple, cutting an estimated $1.38B.
- Goldman Sachs fully exited Allergan plc in Q2 2020, selling an estimated $1.33B.
- Goldman Sachs's ten largest holdings make up 19% of its $329B portfolio in Q2 2020.
- Goldman Sachs opened 507 new positions and closed 535 in Q2 2020.
- Goldman Sachs's portfolio value rose 16% quarter-over-quarter to $329B.
Based on Goldman Sachs's 13F filing for Q2 2020, filed 12 Aug 2020.